Method for treating proliferative disorders associated with protooncogene products

Details for Australian Patent Application No. 2007267843 (hide)

Owner Synta Pharmaceuticals Corp.

Inventors Foley, Kevin; Du, Zhenjian

Agent Davies Collison Cave

Pub. Number AU-B-2007267843

PCT Pub. Number WO2007/139951

Priority 60/808,296 25.05.06 US; 60/808,361 25.05.06 US; 60/808,363 25.05.06 US; 60/808,249 25.05.06 US

Filing date 25 May 2007

Wipo publication date 6 December 2007

Acceptance publication date 13 October 2011

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4152 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4166 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/4188 (2006.01)

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/4439 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/52 (2006.01)

A61K 31/5377 (2006.01)

A61K 31/538 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

29 January 2009 PCT application entered the National Phase

  PCT publication WO2007/139951 Priority application(s): WO2007/139951

13 October 2011 Application Accepted

  Published as AU-B-2007267843

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007267847-Triazole compounds that modulate Hsp90 activity

2007267842-Isothiazolinone biocides enhanced by zinc ions